nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—RRM2—polycystic ovary syndrome	0.564	1	CbGaD
Cladribine—SLC22A2—Metformin—polycystic ovary syndrome	0.0914	0.535	CbGbCtD
Cladribine—SLC22A1—Metformin—polycystic ovary syndrome	0.0794	0.465	CbGbCtD
Cladribine—NR5A1—corpus luteum—polycystic ovary syndrome	0.0175	0.15	CbGeAlD
Cladribine—NR5A1—ovarian follicle—polycystic ovary syndrome	0.0137	0.118	CbGeAlD
Cladribine—POLE4—embryo—polycystic ovary syndrome	0.00393	0.0338	CbGeAlD
Cladribine—POLE2—embryo—polycystic ovary syndrome	0.00344	0.0296	CbGeAlD
Cladribine—POLE2—endometrium—polycystic ovary syndrome	0.00252	0.0216	CbGeAlD
Cladribine—POLE2—adrenal gland—polycystic ovary syndrome	0.00203	0.0175	CbGeAlD
Cladribine—POLE4—endocrine gland—polycystic ovary syndrome	0.00202	0.0174	CbGeAlD
Cladribine—POLE3—embryo—polycystic ovary syndrome	0.00191	0.0164	CbGeAlD
Cladribine—POLE2—female gonad—polycystic ovary syndrome	0.0019	0.0163	CbGeAlD
Cladribine—POLE2—vagina—polycystic ovary syndrome	0.00188	0.0162	CbGeAlD
Cladribine—RRM2B—adrenal cortex—polycystic ovary syndrome	0.00165	0.0142	CbGeAlD
Cladribine—POLE3—adrenal cortex—polycystic ovary syndrome	0.00156	0.0134	CbGeAlD
Cladribine—Clofarabine—RRM2—polycystic ovary syndrome	0.00152	1	CrCbGaD
Cladribine—NR5A1—adrenal cortex—polycystic ovary syndrome	0.00151	0.013	CbGeAlD
Cladribine—RRM2B—endometrium—polycystic ovary syndrome	0.00148	0.0127	CbGeAlD
Cladribine—PNP—uterus—polycystic ovary syndrome	0.00147	0.0126	CbGeAlD
Cladribine—POLE—embryo—polycystic ovary syndrome	0.00146	0.0125	CbGeAlD
Cladribine—POLE3—endometrium—polycystic ovary syndrome	0.0014	0.012	CbGeAlD
Cladribine—RRM2B—pituitary gland—polycystic ovary syndrome	0.00134	0.0115	CbGeAlD
Cladribine—RRM2B—adipose tissue—polycystic ovary syndrome	0.00133	0.0114	CbGeAlD
Cladribine—Fungal infection—Metformin—polycystic ovary syndrome	0.0013	0.0503	CcSEcCtD
Cladribine—POLE3—pituitary gland—polycystic ovary syndrome	0.00126	0.0109	CbGeAlD
Cladribine—POLE3—adipose tissue—polycystic ovary syndrome	0.00126	0.0108	CbGeAlD
Cladribine—NR5A1—pituitary gland—polycystic ovary syndrome	0.00122	0.0105	CbGeAlD
Cladribine—Blood disorder—Metformin—polycystic ovary syndrome	0.0012	0.0465	CcSEcCtD
Cladribine—PNP—female gonad—polycystic ovary syndrome	0.0012	0.0103	CbGeAlD
Cladribine—RRM2—embryo—polycystic ovary syndrome	0.0012	0.0103	CbGeAlD
Cladribine—RRM2B—adrenal gland—polycystic ovary syndrome	0.00119	0.0103	CbGeAlD
Cladribine—SLC28A3—adipose tissue—polycystic ovary syndrome	0.00118	0.0101	CbGeAlD
Cladribine—Contusion—Metformin—polycystic ovary syndrome	0.00115	0.0445	CcSEcCtD
Cladribine—POLE3—adrenal gland—polycystic ovary syndrome	0.00113	0.00971	CbGeAlD
Cladribine—PNP—endocrine gland—polycystic ovary syndrome	0.00112	0.00959	CbGeAlD
Cladribine—RRM2B—female gonad—polycystic ovary syndrome	0.00111	0.00957	CbGeAlD
Cladribine—RRM2B—vagina—polycystic ovary syndrome	0.00111	0.00952	CbGeAlD
Cladribine—NR5A1—adrenal gland—polycystic ovary syndrome	0.00109	0.00941	CbGeAlD
Cladribine—POLE—endometrium—polycystic ovary syndrome	0.00107	0.00916	CbGeAlD
Cladribine—POLE3—female gonad—polycystic ovary syndrome	0.00105	0.00905	CbGeAlD
Cladribine—POLE3—vagina—polycystic ovary syndrome	0.00105	0.009	CbGeAlD
Cladribine—RRM2B—endocrine gland—polycystic ovary syndrome	0.00104	0.0089	CbGeAlD
Cladribine—NR5A1—female gonad—polycystic ovary syndrome	0.00102	0.00877	CbGeAlD
Cladribine—SLC28A3—female gonad—polycystic ovary syndrome	0.000985	0.00847	CbGeAlD
Cladribine—POLE3—endocrine gland—polycystic ovary syndrome	0.000979	0.00842	CbGeAlD
Cladribine—POLE—pituitary gland—polycystic ovary syndrome	0.000964	0.00829	CbGeAlD
Cladribine—POLE—adipose tissue—polycystic ovary syndrome	0.00096	0.00826	CbGeAlD
Cladribine—NR5A1—endocrine gland—polycystic ovary syndrome	0.000948	0.00816	CbGeAlD
Cladribine—POLA1—endometrium—polycystic ovary syndrome	0.000918	0.0079	CbGeAlD
Cladribine—RRM2—endometrium—polycystic ovary syndrome	0.000877	0.00754	CbGeAlD
Cladribine—POLE—adrenal gland—polycystic ovary syndrome	0.000861	0.00741	CbGeAlD
Cladribine—POLA1—pituitary gland—polycystic ovary syndrome	0.000831	0.00714	CbGeAlD
Cladribine—POLA1—adipose tissue—polycystic ovary syndrome	0.000827	0.00712	CbGeAlD
Cladribine—RRM1—adrenal cortex—polycystic ovary syndrome	0.000816	0.00702	CbGeAlD
Cladribine—RRM2—uterus—polycystic ovary syndrome	0.000808	0.00695	CbGeAlD
Cladribine—POLE—female gonad—polycystic ovary syndrome	0.000803	0.0069	CbGeAlD
Cladribine—POLE—vagina—polycystic ovary syndrome	0.000798	0.00686	CbGeAlD
Cladribine—RRM2—pituitary gland—polycystic ovary syndrome	0.000794	0.00683	CbGeAlD
Cladribine—RRM2—adipose tissue—polycystic ovary syndrome	0.00079	0.0068	CbGeAlD
Cladribine—DCK—embryo—polycystic ovary syndrome	0.000773	0.00665	CbGeAlD
Cladribine—Renal impairment—Metformin—polycystic ovary syndrome	0.000767	0.0296	CcSEcCtD
Cladribine—POLE—endocrine gland—polycystic ovary syndrome	0.000747	0.00642	CbGeAlD
Cladribine—Lethargy—Metformin—polycystic ovary syndrome	0.000744	0.0288	CcSEcCtD
Cladribine—POLA1—adrenal gland—polycystic ovary syndrome	0.000742	0.00638	CbGeAlD
Cladribine—Pain in extremity—Metformin—polycystic ovary syndrome	0.00073	0.0282	CcSEcCtD
Cladribine—RRM1—endometrium—polycystic ovary syndrome	0.000729	0.00627	CbGeAlD
Cladribine—RRM2—adrenal gland—polycystic ovary syndrome	0.000709	0.0061	CbGeAlD
Cladribine—POLA1—female gonad—polycystic ovary syndrome	0.000692	0.00595	CbGeAlD
Cladribine—POLA1—vagina—polycystic ovary syndrome	0.000688	0.00592	CbGeAlD
Cladribine—RRM1—uterus—polycystic ovary syndrome	0.000671	0.00577	CbGeAlD
Cladribine—RRM2—female gonad—polycystic ovary syndrome	0.000661	0.00569	CbGeAlD
Cladribine—RRM1—pituitary gland—polycystic ovary syndrome	0.000659	0.00567	CbGeAlD
Cladribine—RRM2—vagina—polycystic ovary syndrome	0.000657	0.00565	CbGeAlD
Cladribine—RRM1—adipose tissue—polycystic ovary syndrome	0.000657	0.00565	CbGeAlD
Cladribine—DCK—adrenal cortex—polycystic ovary syndrome	0.000634	0.00545	CbGeAlD
Cladribine—RRM2—endocrine gland—polycystic ovary syndrome	0.000615	0.00529	CbGeAlD
Cladribine—Sweating increased—Metformin—polycystic ovary syndrome	0.000614	0.0237	CcSEcCtD
Cladribine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000604	0.0234	CcSEcCtD
Cladribine—Neutropenia—Metformin—polycystic ovary syndrome	0.00059	0.0228	CcSEcCtD
Cladribine—RRM1—adrenal gland—polycystic ovary syndrome	0.000589	0.00507	CbGeAlD
Cladribine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000586	0.0226	CcSEcCtD
Cladribine—DCK—endometrium—polycystic ovary syndrome	0.000566	0.00487	CbGeAlD
Cladribine—Infestation NOS—Metformin—polycystic ovary syndrome	0.000562	0.0217	CcSEcCtD
Cladribine—Infestation—Metformin—polycystic ovary syndrome	0.000562	0.0217	CcSEcCtD
Cladribine—RRM1—female gonad—polycystic ovary syndrome	0.000549	0.00472	CbGeAlD
Cladribine—RRM1—vagina—polycystic ovary syndrome	0.000546	0.0047	CbGeAlD
Cladribine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000532	0.0205	CcSEcCtD
Cladribine—DCK—uterus—polycystic ovary syndrome	0.000521	0.00449	CbGeAlD
Cladribine—DCK—pituitary gland—polycystic ovary syndrome	0.000512	0.0044	CbGeAlD
Cladribine—RRM1—endocrine gland—polycystic ovary syndrome	0.000511	0.00439	CbGeAlD
Cladribine—DCK—adipose tissue—polycystic ovary syndrome	0.00051	0.00439	CbGeAlD
Cladribine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000497	0.0192	CcSEcCtD
Cladribine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000496	0.0192	CcSEcCtD
Cladribine—Eye disorder—Metformin—polycystic ovary syndrome	0.000472	0.0182	CcSEcCtD
Cladribine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000468	0.0181	CcSEcCtD
Cladribine—Angiopathy—Metformin—polycystic ovary syndrome	0.000458	0.0177	CcSEcCtD
Cladribine—DCK—adrenal gland—polycystic ovary syndrome	0.000457	0.00394	CbGeAlD
Cladribine—Immune system disorder—Metformin—polycystic ovary syndrome	0.000456	0.0176	CcSEcCtD
Cladribine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000455	0.0176	CcSEcCtD
Cladribine—Chills—Metformin—polycystic ovary syndrome	0.000453	0.0175	CcSEcCtD
Cladribine—Erythema—Metformin—polycystic ovary syndrome	0.000439	0.017	CcSEcCtD
Cladribine—Malnutrition—Metformin—polycystic ovary syndrome	0.000439	0.017	CcSEcCtD
Cladribine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.000435	0.00374	CbGeAlD
Cladribine—Flatulence—Metformin—polycystic ovary syndrome	0.000433	0.0167	CcSEcCtD
Cladribine—DCK—female gonad—polycystic ovary syndrome	0.000427	0.00367	CbGeAlD
Cladribine—DCK—vagina—polycystic ovary syndrome	0.000424	0.00365	CbGeAlD
Cladribine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000408	0.0157	CcSEcCtD
Cladribine—DCK—endocrine gland—polycystic ovary syndrome	0.000397	0.00341	CbGeAlD
Cladribine—Malaise—Metformin—polycystic ovary syndrome	0.000396	0.0153	CcSEcCtD
Cladribine—Chest pain—Metformin—polycystic ovary syndrome	0.000374	0.0144	CcSEcCtD
Cladribine—Myalgia—Metformin—polycystic ovary syndrome	0.000374	0.0144	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000371	0.0143	CcSEcCtD
Cladribine—Discomfort—Metformin—polycystic ovary syndrome	0.00037	0.0143	CcSEcCtD
Cladribine—SLC22A1—vagina—polycystic ovary syndrome	0.000362	0.00311	CbGeAlD
Cladribine—Oedema—Metformin—polycystic ovary syndrome	0.000359	0.0139	CcSEcCtD
Cladribine—Infection—Metformin—polycystic ovary syndrome	0.000356	0.0138	CcSEcCtD
Cladribine—ABCG2—adrenal cortex—polycystic ovary syndrome	0.000354	0.00304	CbGeAlD
Cladribine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000352	0.0136	CcSEcCtD
Cladribine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000351	0.0136	CcSEcCtD
Cladribine—Skin disorder—Metformin—polycystic ovary syndrome	0.000348	0.0135	CcSEcCtD
Cladribine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000347	0.0134	CcSEcCtD
Cladribine—Anorexia—Metformin—polycystic ovary syndrome	0.000342	0.0132	CcSEcCtD
Cladribine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.000338	0.00291	CbGeAlD
Cladribine—Hypotension—Metformin—polycystic ovary syndrome	0.000335	0.0129	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000327	0.0126	CcSEcCtD
Cladribine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000322	0.0124	CcSEcCtD
Cladribine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00032	0.0123	CcSEcCtD
Cladribine—Somnolence—Metformin—polycystic ovary syndrome	0.000319	0.0123	CcSEcCtD
Cladribine—ABCG2—endometrium—polycystic ovary syndrome	0.000316	0.00272	CbGeAlD
Cladribine—Decreased appetite—Metformin—polycystic ovary syndrome	0.000312	0.012	CcSEcCtD
Cladribine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00031	0.012	CcSEcCtD
Cladribine—Fatigue—Metformin—polycystic ovary syndrome	0.000309	0.0119	CcSEcCtD
Cladribine—Constipation—Metformin—polycystic ovary syndrome	0.000307	0.0118	CcSEcCtD
Cladribine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000295	0.0114	CcSEcCtD
Cladribine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000293	0.0113	CcSEcCtD
Cladribine—ABCG2—uterus—polycystic ovary syndrome	0.000291	0.0025	CbGeAlD
Cladribine—ABCG2—pituitary gland—polycystic ovary syndrome	0.000286	0.00246	CbGeAlD
Cladribine—Urticaria—Metformin—polycystic ovary syndrome	0.000285	0.011	CcSEcCtD
Cladribine—ABCG2—adipose tissue—polycystic ovary syndrome	0.000285	0.00245	CbGeAlD
Cladribine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000283	0.0109	CcSEcCtD
Cladribine—Asthenia—Metformin—polycystic ovary syndrome	0.000257	0.00994	CcSEcCtD
Cladribine—ABCG2—adrenal gland—polycystic ovary syndrome	0.000255	0.0022	CbGeAlD
Cladribine—Pruritus—Metformin—polycystic ovary syndrome	0.000254	0.0098	CcSEcCtD
Cladribine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000245	0.00948	CcSEcCtD
Cladribine—ABCG2—female gonad—polycystic ovary syndrome	0.000238	0.00205	CbGeAlD
Cladribine—Dizziness—Metformin—polycystic ovary syndrome	0.000237	0.00916	CcSEcCtD
Cladribine—ABCG2—vagina—polycystic ovary syndrome	0.000237	0.00203	CbGeAlD
Cladribine—Vomiting—Metformin—polycystic ovary syndrome	0.000228	0.00881	CcSEcCtD
Cladribine—Rash—Metformin—polycystic ovary syndrome	0.000226	0.00873	CcSEcCtD
Cladribine—Dermatitis—Metformin—polycystic ovary syndrome	0.000226	0.00873	CcSEcCtD
Cladribine—Headache—Metformin—polycystic ovary syndrome	0.000225	0.00868	CcSEcCtD
Cladribine—Nausea—Metformin—polycystic ovary syndrome	0.000213	0.00823	CcSEcCtD
Cladribine—POLE—Cell Cycle—TOP2A—polycystic ovary syndrome	5.88e-05	0.000487	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—LEP—polycystic ovary syndrome	5.82e-05	0.000481	CbGpPWpGaD
Cladribine—RRM1—Metabolism—STAR—polycystic ovary syndrome	5.81e-05	0.00048	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKR1C3—polycystic ovary syndrome	5.71e-05	0.000473	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—CCNB1—polycystic ovary syndrome	5.64e-05	0.000467	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP17A1—polycystic ovary syndrome	5.62e-05	0.000465	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—TH—polycystic ovary syndrome	5.61e-05	0.000464	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	5.57e-05	0.000461	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	5.57e-05	0.000461	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CCNB1—polycystic ovary syndrome	5.52e-05	0.000457	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	5.51e-05	0.000456	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—SLC2A4—polycystic ovary syndrome	5.46e-05	0.000452	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	5.44e-05	0.00045	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	5.38e-05	0.000445	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—TNRC6B—polycystic ovary syndrome	5.38e-05	0.000445	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—PGR—polycystic ovary syndrome	5.32e-05	0.00044	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CCNB1—polycystic ovary syndrome	5.3e-05	0.000438	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PNPLA2—polycystic ovary syndrome	5.29e-05	0.000437	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	5.26e-05	0.000435	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	5.19e-05	0.000429	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	5.18e-05	0.000429	CbGpPWpGaD
Cladribine—RRM1—Metabolism—HMMR—polycystic ovary syndrome	5.18e-05	0.000428	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	5.14e-05	0.000425	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CYP19A1—polycystic ovary syndrome	5.13e-05	0.000425	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—PPARG—polycystic ovary syndrome	5.07e-05	0.000419	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	5.04e-05	0.000417	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SRD5A1—polycystic ovary syndrome	5.01e-05	0.000415	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	4.99e-05	0.000413	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—RRM2—polycystic ovary syndrome	4.98e-05	0.000412	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—INS—polycystic ovary syndrome	4.97e-05	0.000411	CbGpPWpGaD
Cladribine—DCK—Metabolism—PNPLA2—polycystic ovary syndrome	4.94e-05	0.000409	CbGpPWpGaD
Cladribine—RRM1—Metabolism—HSD3B1—polycystic ovary syndrome	4.94e-05	0.000409	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	4.89e-05	0.000405	CbGpPWpGaD
Cladribine—PNP—Metabolism—TH—polycystic ovary syndrome	4.87e-05	0.000403	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.85e-05	0.000401	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	4.83e-05	0.0004	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—AKT2—polycystic ovary syndrome	4.8e-05	0.000397	CbGpPWpGaD
Cladribine—RRM2—Metabolism—STAR—polycystic ovary syndrome	4.78e-05	0.000396	CbGpPWpGaD
Cladribine—PNP—Metabolism—SLC2A4—polycystic ovary syndrome	4.73e-05	0.000392	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MAD2L1—polycystic ovary syndrome	4.7e-05	0.000389	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	4.69e-05	0.000388	CbGpPWpGaD
Cladribine—DCK—Metabolism—SRD5A1—polycystic ovary syndrome	4.68e-05	0.000388	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	4.65e-05	0.000385	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	4.58e-05	0.000379	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GNAS—polycystic ovary syndrome	4.58e-05	0.000379	CbGpPWpGaD
Cladribine—RRM1—Metabolism—LHB—polycystic ovary syndrome	4.5e-05	0.000373	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.48e-05	0.00037	CbGpPWpGaD
Cladribine—DCK—Metabolism—STAR—polycystic ovary syndrome	4.47e-05	0.00037	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP19A1—polycystic ovary syndrome	4.45e-05	0.000368	CbGpPWpGaD
Cladribine—RRM1—Metabolism—HSD3B2—polycystic ovary syndrome	4.4e-05	0.000364	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—LMNA—polycystic ovary syndrome	4.37e-05	0.000362	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—NCOR1—polycystic ovary syndrome	4.37e-05	0.000361	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	4.27e-05	0.000353	CbGpPWpGaD
Cladribine—RRM2—Metabolism—HMMR—polycystic ovary syndrome	4.26e-05	0.000353	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKR1C1—polycystic ovary syndrome	4.26e-05	0.000353	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	4.22e-05	0.000349	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TOP2A—polycystic ovary syndrome	4.19e-05	0.000347	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AR—polycystic ovary syndrome	4.14e-05	0.000342	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CYP1A1—polycystic ovary syndrome	4.14e-05	0.000342	CbGpPWpGaD
Cladribine—RRM2—Metabolism—HSD3B1—polycystic ovary syndrome	4.07e-05	0.000336	CbGpPWpGaD
Cladribine—DCK—Metabolism—HMMR—polycystic ovary syndrome	3.98e-05	0.00033	CbGpPWpGaD
Cladribine—PNP—Metabolism—GNAS—polycystic ovary syndrome	3.97e-05	0.000329	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—CAMK2D—polycystic ovary syndrome	3.97e-05	0.000329	CbGpPWpGaD
Cladribine—RRM1—Metabolism—SULT2A1—polycystic ovary syndrome	3.92e-05	0.000325	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.91e-05	0.000323	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—MTHFR—polycystic ovary syndrome	3.86e-05	0.000319	CbGpPWpGaD
Cladribine—DCK—Metabolism—HSD3B1—polycystic ovary syndrome	3.8e-05	0.000314	CbGpPWpGaD
Cladribine—RRM1—Metabolism—RRM2—polycystic ovary syndrome	3.8e-05	0.000314	CbGpPWpGaD
Cladribine—PNP—Metabolism—NCOR1—polycystic ovary syndrome	3.78e-05	0.000313	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCNB1—polycystic ovary syndrome	3.77e-05	0.000312	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	3.74e-05	0.000309	CbGpPWpGaD
Cladribine—RRM2—Metabolism—LHB—polycystic ovary syndrome	3.71e-05	0.000307	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—CAMK2D—polycystic ovary syndrome	3.7e-05	0.000306	CbGpPWpGaD
Cladribine—RRM1—Metabolism—YAP1—polycystic ovary syndrome	3.66e-05	0.000303	CbGpPWpGaD
Cladribine—RRM2—Metabolism—HSD3B2—polycystic ovary syndrome	3.62e-05	0.0003	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NCOR1—polycystic ovary syndrome	3.62e-05	0.000299	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP1A1—polycystic ovary syndrome	3.59e-05	0.000297	CbGpPWpGaD
Cladribine—RRM1—Metabolism—NAMPT—polycystic ovary syndrome	3.52e-05	0.000291	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—DLG4—polycystic ovary syndrome	3.51e-05	0.000291	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKR1C1—polycystic ovary syndrome	3.51e-05	0.00029	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	3.48e-05	0.000288	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP11A1—polycystic ovary syndrome	3.47e-05	0.000287	CbGpPWpGaD
Cladribine—DCK—Metabolism—LHB—polycystic ovary syndrome	3.47e-05	0.000287	CbGpPWpGaD
Cladribine—DCK—Metabolism—HSD3B2—polycystic ovary syndrome	3.39e-05	0.00028	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NR3C1—polycystic ovary syndrome	3.35e-05	0.000277	CbGpPWpGaD
Cladribine—PNP—Metabolism—MTHFR—polycystic ovary syndrome	3.34e-05	0.000277	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKR1C3—polycystic ovary syndrome	3.28e-05	0.000271	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKR1C1—polycystic ovary syndrome	3.28e-05	0.000271	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—DLG4—polycystic ovary syndrome	3.27e-05	0.000271	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NMNAT3—polycystic ovary syndrome	3.26e-05	0.00027	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	3.25e-05	0.000268	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SULT2A1—polycystic ovary syndrome	3.23e-05	0.000267	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP17A1—polycystic ovary syndrome	3.23e-05	0.000267	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NMNAT3—polycystic ovary syndrome	3.23e-05	0.000267	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—VEGFA—polycystic ovary syndrome	3.14e-05	0.00026	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PPARG—polycystic ovary syndrome	3.13e-05	0.000259	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—POMC—polycystic ovary syndrome	3.09e-05	0.000255	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—INS—polycystic ovary syndrome	3.07e-05	0.000254	CbGpPWpGaD
Cladribine—DCK—Metabolism—SULT2A1—polycystic ovary syndrome	3.02e-05	0.00025	CbGpPWpGaD
Cladribine—RRM2—Metabolism—YAP1—polycystic ovary syndrome	3.02e-05	0.00025	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NMNAT3—polycystic ovary syndrome	3.01e-05	0.000249	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LPCAT2—polycystic ovary syndrome	2.99e-05	0.000247	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SUOX—polycystic ovary syndrome	2.99e-05	0.000247	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LPCAT2—polycystic ovary syndrome	2.95e-05	0.000244	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SUOX—polycystic ovary syndrome	2.95e-05	0.000244	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.92e-05	0.000242	CbGpPWpGaD
Cladribine—DCK—Metabolism—RRM2—polycystic ovary syndrome	2.92e-05	0.000242	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NAMPT—polycystic ovary syndrome	2.9e-05	0.00024	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP11A1—polycystic ovary syndrome	2.86e-05	0.000237	CbGpPWpGaD
Cladribine—DCK—Metabolism—YAP1—polycystic ovary syndrome	2.82e-05	0.000233	CbGpPWpGaD
Cladribine—RRM1—Metabolism—TH—polycystic ovary syndrome	2.8e-05	0.000231	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ISYNA1—polycystic ovary syndrome	2.78e-05	0.00023	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LPCAT2—polycystic ovary syndrome	2.75e-05	0.000228	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SUOX—polycystic ovary syndrome	2.75e-05	0.000228	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ISYNA1—polycystic ovary syndrome	2.75e-05	0.000227	CbGpPWpGaD
Cladribine—RRM1—Metabolism—SLC2A4—polycystic ovary syndrome	2.72e-05	0.000225	CbGpPWpGaD
Cladribine—PNP—Metabolism—PPARG—polycystic ovary syndrome	2.71e-05	0.000224	CbGpPWpGaD
Cladribine—DCK—Metabolism—NAMPT—polycystic ovary syndrome	2.71e-05	0.000224	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKR1C3—polycystic ovary syndrome	2.7e-05	0.000224	CbGpPWpGaD
Cladribine—PNP—Metabolism—POMC—polycystic ovary syndrome	2.68e-05	0.000221	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP11A1—polycystic ovary syndrome	2.67e-05	0.000221	CbGpPWpGaD
Cladribine—PNP—Metabolism—INS—polycystic ovary syndrome	2.66e-05	0.00022	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP17A1—polycystic ovary syndrome	2.66e-05	0.00022	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—PPARG—polycystic ovary syndrome	2.59e-05	0.000214	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ISYNA1—polycystic ovary syndrome	2.56e-05	0.000212	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP19A1—polycystic ovary syndrome	2.56e-05	0.000212	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKR1C3—polycystic ovary syndrome	2.53e-05	0.000209	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP17A1—polycystic ovary syndrome	2.49e-05	0.000206	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TEAD2—polycystic ovary syndrome	2.36e-05	0.000195	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKR1C2—polycystic ovary syndrome	2.36e-05	0.000195	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TEAD2—polycystic ovary syndrome	2.34e-05	0.000193	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKR1C2—polycystic ovary syndrome	2.34e-05	0.000193	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—SERPINE1—polycystic ovary syndrome	2.34e-05	0.000193	CbGpPWpGaD
Cladribine—RRM2—Metabolism—TH—polycystic ovary syndrome	2.3e-05	0.00019	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GNAS—polycystic ovary syndrome	2.28e-05	0.000189	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SLC2A4—polycystic ovary syndrome	2.24e-05	0.000185	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKR1C2—polycystic ovary syndrome	2.18e-05	0.00018	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TEAD2—polycystic ovary syndrome	2.18e-05	0.00018	CbGpPWpGaD
Cladribine—RRM1—Metabolism—NCOR1—polycystic ovary syndrome	2.17e-05	0.00018	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—IL6—polycystic ovary syndrome	2.17e-05	0.00018	CbGpPWpGaD
Cladribine—DCK—Metabolism—TH—polycystic ovary syndrome	2.15e-05	0.000178	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP19A1—polycystic ovary syndrome	2.11e-05	0.000174	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.1e-05	0.000174	CbGpPWpGaD
Cladribine—DCK—Metabolism—SLC2A4—polycystic ovary syndrome	2.09e-05	0.000173	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.08e-05	0.000172	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP1A1—polycystic ovary syndrome	2.06e-05	0.00017	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PNPLA2—polycystic ovary syndrome	1.98e-05	0.000164	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP19A1—polycystic ovary syndrome	1.97e-05	0.000163	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PNPLA2—polycystic ovary syndrome	1.96e-05	0.000162	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.95e-05	0.000162	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.94e-05	0.00016	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.93e-05	0.00016	CbGpPWpGaD
Cladribine—RRM1—Metabolism—MTHFR—polycystic ovary syndrome	1.92e-05	0.000159	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GNAS—polycystic ovary syndrome	1.88e-05	0.000155	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SRD5A1—polycystic ovary syndrome	1.87e-05	0.000155	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SRD5A1—polycystic ovary syndrome	1.86e-05	0.000153	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PNPLA2—polycystic ovary syndrome	1.82e-05	0.000151	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.8e-05	0.000149	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NCOR1—polycystic ovary syndrome	1.79e-05	0.000148	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—STAR—polycystic ovary syndrome	1.79e-05	0.000148	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.79e-05	0.000148	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	1.77e-05	0.000146	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.77e-05	0.000146	CbGpPWpGaD
Cladribine—DCK—Metabolism—GNAS—polycystic ovary syndrome	1.76e-05	0.000145	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	1.73e-05	0.000143	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP1A1—polycystic ovary syndrome	1.7e-05	0.00014	CbGpPWpGaD
Cladribine—DCK—Metabolism—NCOR1—polycystic ovary syndrome	1.67e-05	0.000138	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	1.65e-05	0.000136	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.65e-05	0.000136	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HMMR—polycystic ovary syndrome	1.59e-05	0.000132	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP1A1—polycystic ovary syndrome	1.59e-05	0.000131	CbGpPWpGaD
Cladribine—RRM2—Metabolism—MTHFR—polycystic ovary syndrome	1.58e-05	0.000131	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	1.58e-05	0.000131	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PPARG—polycystic ovary syndrome	1.56e-05	0.000129	CbGpPWpGaD
Cladribine—RRM1—Metabolism—POMC—polycystic ovary syndrome	1.54e-05	0.000127	CbGpPWpGaD
Cladribine—RRM1—Metabolism—INS—polycystic ovary syndrome	1.53e-05	0.000126	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HSD3B1—polycystic ovary syndrome	1.52e-05	0.000126	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.51e-05	0.000125	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.5e-05	0.000124	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.48e-05	0.000123	CbGpPWpGaD
Cladribine—DCK—Metabolism—MTHFR—polycystic ovary syndrome	1.48e-05	0.000122	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	1.47e-05	0.000122	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	1.4e-05	0.000116	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LHB—polycystic ovary syndrome	1.39e-05	0.000115	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.38e-05	0.000114	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	1.37e-05	0.000114	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HSD3B2—polycystic ovary syndrome	1.36e-05	0.000112	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.34e-05	0.000111	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKR1C1—polycystic ovary syndrome	1.31e-05	0.000109	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.3e-05	0.000107	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARG—polycystic ovary syndrome	1.28e-05	0.000106	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	1.28e-05	0.000106	CbGpPWpGaD
Cladribine—RRM2—Metabolism—POMC—polycystic ovary syndrome	1.27e-05	0.000105	CbGpPWpGaD
Cladribine—RRM2—Metabolism—INS—polycystic ovary syndrome	1.26e-05	0.000104	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	1.25e-05	0.000103	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	1.21e-05	0.0001	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	1.21e-05	9.99e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARG—polycystic ovary syndrome	1.2e-05	9.92e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.2e-05	9.89e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—POMC—polycystic ovary syndrome	1.18e-05	9.78e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—INS—polycystic ovary syndrome	1.18e-05	9.73e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	1.17e-05	9.68e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	1.16e-05	9.58e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	1.13e-05	9.33e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	1.12e-05	9.23e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	1.11e-05	9.22e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	1.08e-05	8.96e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	1.08e-05	8.93e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	1.07e-05	8.87e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	1.07e-05	8.85e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.06e-05	8.76e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	1.04e-05	8.61e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	1.01e-05	8.36e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	1e-05	8.27e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	1e-05	8.27e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	9.95e-06	8.23e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	9.87e-06	8.17e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	9.85e-06	8.15e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	9.32e-06	7.71e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	9.18e-06	7.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TH—polycystic ovary syndrome	8.61e-06	7.12e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TH—polycystic ovary syndrome	8.52e-06	7.05e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	8.37e-06	6.93e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	8.29e-06	6.86e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	7.94e-06	6.57e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	7.87e-06	6.51e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	7.79e-06	6.45e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	7.72e-06	6.39e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	7.26e-06	6.01e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	7.03e-06	5.81e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	6.95e-06	5.75e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	6.69e-06	5.54e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	6.63e-06	5.48e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	6.48e-06	5.36e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	6.35e-06	5.25e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	6.28e-06	5.2e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	6.18e-06	5.11e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	5.92e-06	4.89e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	5.86e-06	4.84e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	5.85e-06	4.84e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	5.46e-06	4.51e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	4.8e-06	3.97e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	4.75e-06	3.93e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—POMC—polycystic ovary syndrome	4.73e-06	3.91e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—INS—polycystic ovary syndrome	4.71e-06	3.89e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	4.68e-06	3.87e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	4.66e-06	3.85e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	4.43e-06	3.66e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	4.36e-06	3.61e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	4.34e-06	3.59e-05	CbGpPWpGaD
